Laboratory Corporation of America Holdings (LH)
Largest Insider Buys in Sector
LH Stock Price History Chart
LH Stock Performance
About Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C …
Insider Activity of Laboratory Corporation of America Holdings
Over the last 12 months, insiders at Laboratory Corporation of America Holdings have bought $0 and sold $25.54M worth of Laboratory Corporation of America Holdings stock.
On average, over the past 5 years, insiders at Laboratory Corporation of America Holdings have bought $1.04M and sold $16.07M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 44 shares for transaction amount of $10,251 was made by Caveney Brian J (EVP, President of Diagnostics) on 2022‑09‑07.
List of Insider Buy and Sell Transactions, Laboratory Corporation of America Holdings
| 2024-12-02 | Sale | Executive Vice President | 11,711 0.014% | $240.43 | $2.82M | -3.47% | ||
| 2024-12-02 | Sale | director | 1,000 0.0012% | $241.00 | $241,000 | -3.47% | ||
| 2024-11-22 | Sale | EVP, Chief Marketing Officer | 3,671.5 0.0044% | $238.91 | $877,142 | -1.99% | ||
| 2024-11-21 | Sale | EVP, Chief Legal Officer | 1,000 0.0012% | $239.42 | $239,419 | -1.97% | ||
| 2024-11-11 | Sale | President & CEO | 6,189 0.0074% | $243.47 | $1.51M | -2.68% | ||
| 2024-10-24 | Sale | director | 1,000 0.0012% | $230.00 | $230,000 | 0.00% | ||
| 2024-08-19 | Sale | EVP, Chief Legal Officer | 2,000 0.0024% | $227.05 | $454,100 | +1.13% | ||
| 2024-08-15 | Sale | Chief Financial Officer, EVP | 15,000 0.0179% | $223.99 | $3.36M | 0.00% | ||
| 2024-08-08 | Sale | director | 586 0.0007% | $225.00 | $131,850 | +1.57% | ||
| 2024-08-07 | Sale | director | 414 0.0005% | $225.00 | $93,150 | +4.02% | ||
| 2024-08-05 | Sale | EVP, CIO & CTO | 12,093 0.0144% | $229.10 | $2.77M | -0.21% | ||
| 2024-05-14 | Sale | EVP, Chief Legal Officer | 2,000 0.0024% | $210.83 | $421,655 | +5.78% | ||
| 2024-05-02 | Sale | director | 250 0.0003% | $200.10 | $50,025 | +10.23% | ||
| 2024-04-30 | Sale | director | 250 0.0003% | $204.13 | $51,034 | +9.35% | ||
| 2024-04-29 | Sale | SVP, Chief Accounting Officer | 2,439 0.0029% | $204.33 | $498,358 | +7.74% | ||
| 2024-04-01 | Sale | EVP, Pres Diagnostics & COO | 6,477 0.0077% | $217.29 | $1.41M | -0.26% | ||
| 2024-04-01 | Sale | EVP, Chief Marketing Officer | 3,500 0.0042% | $217.29 | $760,515 | -0.26% | ||
| 2024-03-28 | Sale | EVP, Chief Legal Officer | 3,553 0.0042% | $216.74 | $770,077 | -1.18% | ||
| 2024-03-07 | Sale | EVP, Pres Diagnostics & COO | 5,048 0.006% | $218.45 | $1.1M | -1.19% | ||
| 2024-03-07 | Sale | EVP, Chief Marketing Officer | 227 0.0003% | $218.45 | $49,588 | -1.19% |
Insider Historical Profitability
| LANE WENDY E | director | 17395 0.0208% | $228.61 | 1 | 8 | +3.62% |
| Caveney Brian J | EVP, President of Diagnostics | 14282 0.0171% | $228.61 | 2 | 0 | <0.0001% |
| NEUPERT PETER M | director | 10254 0.0123% | $228.61 | 1 | 0 | <0.0001% |
| Conrad Andrew J | EVP, Chief Scientific Officer | 6100 0.0073% | $228.61 | 1 | 1 | +19.38% |
| Watson Craig M | director | 1288 0.0015% | $228.61 | 1 | 6 | +22.07% |
Institutional Investor Ownership
| The Vanguard Group | $2.11B | 11.43 | 9.64M | -1.12% | -$23.87M | 0.04 | |
| BlackRock | $2.06B | 11.19 | 9.43M | -10.06% | -$230.42M | 0.05 | |
| State Street | $804.73M | 4.37 | 3.68M | -2.3% | -$18.93M | 0.03 | |
| Wellington Management Company | $487.81M | 2.65 | 2.23M | -0.67% | -$3.31M | 0.08 | |
| Geode Capital Management | $419.88M | 2.29 | 1.93M | +3.03% | +$12.36M | 0.04 |